Format

Send to

Choose Destination
J Pediatr Oncol Nurs. 2015 Nov-Dec;32(6):355-9. doi: 10.1177/1043454215591954.

APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease From Pediatric to Adult Health Care.

Author information

1
Baylor College of Medicine/Texas Children's Hospital, Houston, TX, USA rxbryant@txch.org.
2
St. Jude Children's Research Hospital, Memphis, TN, USA.
3
Boston University School of Medicine/Boston Medical Center, Boston, MA, USA.

Abstract

With advances in medical care, the majority of children with sickle cell disease are surviving to adulthood. Patients, families, and providers now face the need for this growing population to move from pediatric- to adult-focused care. In order to facilitate a successful transfer to adult health care, and prepare young adults for greater independence, it is recommended that all pediatric patients with sickle cell disease receive transition preparation.

ASSOCIATION POSITION:

As the professional voice of pediatric hematology/oncology healthcare practice, the Association of Pediatric Hematology/Oncology Nurses (APHON) and the American Society of Pediatric Hematology Oncology (ASPHO) recommends that the discussion of transition begin early and is presented as part of the natural process of becoming an adult; that patients, providers, and families are all involved in creating a transition plan and assessing transition preparedness annually; and that transfer of care involve direct communication between the pediatric team and the accepting adult provider.

PMID:
26464507
DOI:
10.1177/1043454215591954
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center